Drug Approval | June 01, 2026
Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
The approval marks a major milestone in the global fight against antimicrobial resistance
The approval marks a major milestone in the global fight against antimicrobial resistance
Ariane brings a strong track record within Ardena, including her leadership of the company’s drug product division since 2022
The filing is backed by results from the pivotal SERENA-6 Phase III trial
The move marks one of the most significant coverage expansions yet in obesity care, bringing FDA-approved treatment options further into mainstream insurance plans rather than out-of-pocket reach
The Establishment Inspection Report came following closure of a product- specific pre-approval inspection from March 2 to March 7, 2026
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
A one-shot gene-editing cholesterol therapy could soon be a reality
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
AAV vectors are widely used in gene therapy for their strong therapeutic potential
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
